サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1769901

非侵襲的出生前検査の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)

Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 240 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
非侵襲的出生前検査の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)
出版日: 2025年05月22日
発行: Transparency Market Research
ページ情報: 英文 240 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

非侵襲的出生前検査市場 - 分析範囲

TMRの調査レポート「世界の非侵襲的出生前検査市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の非侵襲的出生前検査市場の収益と予測を提供します。また、2025年から2035年までの世界の非侵襲的出生前検査市場の複合年間成長率（CAGR、%）も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、非侵襲的出生前検査市場を推察しました。

市場概況
市場規模（2024年） 47億米ドル
市場規模（2035年） 132億米ドル
CAGR 9.5%

当レポートでは、世界の非侵襲的出生前検査市場の競合情勢について分析しています。世界の非侵襲的出生前検査市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の非侵襲的出生前検査市場における各企業の属性です。

目次

第1章 序論

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の非侵襲的出生前検査市場分析と予測（2020～2035年）

第5章 主要洞察

  • 技術進歩
  • 主要地域/国における規制状況
  • 価格動向
  • ポーターのファイブフォース分析
  • PESTEL分析
  • バリューチェーン分析
  • エンドユーザーにとっての主要な購入指標
  • 主要な業界イベント（パートナーシップ、コラボレーション、製品承認、合併と買収、資金調達と投資）
  • 競合が提供する製品のベンチマーク

第6章 世界市場の分析と予測：検査の種類別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：検査の種類別（2020～2035年）
    • 遊離DNAスクリーニング検査
    • 血清マーカースクリーニング検査
    • 神経管閉鎖障害検査
    • 超音波検査
  • 市場の魅力：検査の種類別

第7章 世界市場の分析と予測：製品別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：製品別（2020～2035年）
    • 装置
    • キット・試薬
  • 市場の魅力：製品別

第8章 世界市場の分析と予測：技術別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：技術別（2020～2035年）
    • 全ゲノム配列解析
    • SNP分析
    • マイクロアレイ解析
    • ローリングサークル増幅
  • 市場の魅力：技術別

第9章 世界市場の分析と予測：適応症別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：適応症別（2020～2035年）
    • ダウン症候群（21トリソミー）
    • エドワーズ症候群（18トリソミー）
    • パトー症候群（13トリソミー）
    • ターナー症候群（モノソミーX/XO）
    • クラインフェルター症候群（XXY）
    • ヤコブ症候群（XYY）
    • 性別認識
    • その他（トリプルXなど）
  • 市場の魅力：適応症別

第6章 世界市場の分析と予測：エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：エンドユーザー別（2020～2035年）
    • 病院
    • 専門クリニック
    • 診断研究所
    • その他（研究機関等）
  • 市場の魅力：エンドユーザー別

第11章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測（金額ベース）：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米市場の分析と予測

  • 米国
  • カナダ

第13章 欧州市場の分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第14章 アジア太平洋市場の分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他アジア太平洋

第15章 ラテンアメリカ市場の分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ

第16章 中東・アフリカ市場の分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第17章 競合情勢

  • 市場企業・競合マトリックス（企業の階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Natera, Inc.
    • Illumina, Inc
    • PerkinElmer Inc.
    • Eurofins LifeCodexx AG
    • IGENOMIX
    • Pacific Biosciences
    • BGI
    • Laboratory Corporation of America Holdings
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
図表

List of Tables

  • Table 01: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 02: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 03: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 04: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 05: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 09: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 10: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 11: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 12: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 15: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 16: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 17: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 18: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 20: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 21: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 22: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 23: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 24: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 27: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 28: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 29: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 30: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 32: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 33: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 34: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 35: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 36: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 02: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 03: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Cell-Free DNA Screening Test, 2020 to 2035
  • Figure 04: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Serum Marker Screening Test, 2020 to 2035
  • Figure 05: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Neural Tube Defects Test, 2020 to 2035
  • Figure 06: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Ultrasonography, 2020 to 2035
  • Figure 07: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Weight Management, 2020 to 2035
  • Figure 08: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Nutrition, 2020 to 2035
  • Figure 09: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 10: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 11: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 12: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Instruments, 2020 to 2035
  • Figure 13: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Kits & Reagents, 2020 to 2035
  • Figure 14: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 15: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 16: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Whole-Genome Sequencing, 2020 to 2035
  • Figure 17: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by SNP Analysis, 2020 to 2035
  • Figure 18: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Microarray Analysis, 2020 to 2035
  • Figure 19: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Rolling Circle Amplification, 2020 to 2035
  • Figure 20: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 21: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 22: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Down Syndrome (trisomy 21), 2020 to 2035
  • Figure 23: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Edwards syndrome (trisomy 18), 2020 to 2035
  • Figure 24: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Patau syndrome (trisomy 13), 2020 to 2035
  • Figure 25: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Turner Syndrom (Monosomy X/XO), 2020 to 2035
  • Figure 26: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Klinefelter Syndrome (XXY), 2020 to 2035
  • Figure 27: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Jacob's Syndrome (XYY), 2020 to 2035
  • Figure 28: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Gender Identification, 2020 to 2035
  • Figure 29: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 30: Global Non-invasive Prenatal Testing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 31: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user 2025 to 2035
  • Figure 32: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
  • Figure 33: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Diagnostics Laboratories, 2020 to 2035
  • Figure 34: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Specialty Clinics, 2020 to 2035
  • Figure 35: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 36: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 37: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 38: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 39: North America - Non-invasive Prenatal Testing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 40: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 41: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 42: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 43: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 44: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 45: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 46: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 47: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 48: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 49: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 50: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 51: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 52: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 53: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 54: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 55: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 56: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 57: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 58: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 59: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 60: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 61: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 62: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 63: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 64: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 65: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 66: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 67: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 68: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 69: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 70: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 71: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 72: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 73: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 74: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 75: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 76: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 77: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 78: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 79: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 80: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 81: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 82: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 83: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 84: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 85: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 86: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 87: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 88: Latin America- Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 89: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 90: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 91: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 92: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 93: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 94: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 95: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 96: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 97: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 98: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 99: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 100: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 101: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 102: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
目次
Product Code: TMRGL374

Non-invasive Prenatal Testing Market - Scope of Report

TMR's report on the global non-invasive prenatal testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global non-invasive prenatal testing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive prenatal testing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive prenatal testing market.

Market Snapshot
Market Value in 2024US$ 4.7 Bn
Market Value in 2035US$ 13.2 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global non-invasive prenatal testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global non-invasive prenatal testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global non-invasive prenatal testing market.

The report delves into the competitive landscape of the global non-invasive prenatal testing market. Key players operating in the global non-invasive prenatal testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global non-invasive prenatal testing market profiled in this report.

Key Questions Answered in Global non-invasive prenatal testing Market Report:

  • What is the sales/revenue generated by non-invasive prenatal testing across all regions during the forecast period?
  • What are the opportunities in the global non-invasive prenatal testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Non-invasive Prenatal Testing Market - Research Objectives and Research Approach

The comprehensive report on the global non-invasive prenatal testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global non-invasive prenatal testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global non-invasive prenatal testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Non-invasive Prenatal Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, 2020 to 2035

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Pricing Trends
  • 5.3. Regulatory Landscape across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions, funding and investments)
  • 5.9. Benchmarking of the Product Offered by the Competitors

6. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Test Type, 2020 to 2035
    • 6.3.1. Cell-Free DNA Screening Test
    • 6.3.2. Serum Marker Screening Test
    • 6.3.3. Neural Tube Defects Test
    • 6.3.4. Ultrasonography
  • 6.4. Market Attractiveness By Test Type

7. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Product

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Product, 2020 to 2035
    • 7.3.1. Instruments
    • 7.3.2. Kits & Reagents
  • 7.4. Market Attractiveness By Product

8. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Technology, 2020 to 2035
    • 8.3.1. Whole-Genome Sequencing
    • 8.3.2. SNP Analysis
    • 8.3.3. Microarray Analysis
    • 8.3.4. Rolling Circle Amplification
  • 8.4. Market Attractiveness By Technology

9. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Indication, 2020 to 2035
    • 9.3.1. Down Syndrome (trisomy 21)
    • 9.3.2. Edwards syndrome (trisomy 18)
    • 9.3.3. Patau syndrome (trisomy 13)
    • 9.3.4. Turner Syndrom (Monosomy X/XO)
    • 9.3.5. Klinefelter Syndrome (XXY)
    • 9.3.6. Jacob's Syndrome (XYY)
    • 9.3.7. Gender Identification
    • 9.3.8. Others (Triple X, etc.)
  • 9.4. Market Attractiveness By Indication

10. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By End-user, 2020 to 2035
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostics Laboratories
    • 10.3.4. Others (Research Institutes, etc.)
  • 10.4. Market Attractiveness By End-user

11. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Test Type, 2020 to 2035
    • 12.2.1. Cell-Free DNA Screening Test
    • 12.2.2. Serum Marker Screening Test
    • 12.2.3. Neural Tube Defects Test
    • 12.2.4. Ultrasonography
  • 12.3. Market Value Forecast By Product, 2020 to 2035
    • 12.3.1. Instruments
    • 12.3.2. Kits & Reagents
  • 12.4. Market Value Forecast By Technology, 2020 to 2035
    • 12.4.1. Whole-Genome Sequencing
    • 12.4.2. SNP Analysis
    • 12.4.3. Microarray Analysis
    • 12.4.4. Rolling Circle Amplification
  • 12.5. Market Value Forecast By Indication, 2020 to 2035
    • 12.5.1. Down Syndrome (trisomy 21)
    • 12.5.2. Edwards syndrome (trisomy 18)
    • 12.5.3. Patau syndrome (trisomy 13)
    • 12.5.4. Turner Syndrom (Monosomy X/XO)
    • 12.5.5. Klinefelter Syndrome (XXY)
    • 12.5.6. Jacob's Syndrome (XYY)
    • 12.5.7. Gender Identification
    • 12.5.8. Others (Triple X, etc.)
  • 12.6. Market Value Forecast By End-user, 2020 to 2035
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Diagnostics Laboratories
    • 12.6.4. Others (Research Institutes, etc.)
  • 12.7. Market Value Forecast By Country, 2020 to 2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Test Type
    • 12.8.2. By Product
    • 12.8.3. By Technology
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Non-invasive Prenatal Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Test Type, 2020 to 2035
    • 13.2.1. Cell-Free DNA Screening Test
    • 13.2.2. Serum Marker Screening Test
    • 13.2.3. Neural Tube Defects Test
    • 13.2.4. Ultrasonography
  • 13.3. Market Value Forecast By Product, 2020 to 2035
    • 13.3.1. Instruments
    • 13.3.2. Kits & Reagents
  • 13.4. Market Value Forecast By Technology, 2020 to 2035
    • 13.4.1. Whole-Genome Sequencing
    • 13.4.2. SNP Analysis
    • 13.4.3. Microarray Analysis
    • 13.4.4. Rolling Circle Amplification
  • 13.5. Market Value Forecast By Indication, 2020 to 2035
    • 13.5.1. Down Syndrome (trisomy 21)
    • 13.5.2. Edwards syndrome (trisomy 18)
    • 13.5.3. Patau syndrome (trisomy 13)
    • 13.5.4. Turner Syndrom (Monosomy X/XO)
    • 13.5.5. Klinefelter Syndrome (XXY)
    • 13.5.6. Jacob's Syndrome (XYY)
    • 13.5.7. Gender Identification
    • 13.5.8. Others (Triple X, etc.)
  • 13.6. Market Value Forecast By End-user ,2020 to 2035
    • 13.6.1. Hospitals
    • 13.6.2. Specialty Clinics
    • 13.6.3. Diagnostics Laboratories
    • 13.6.4. Others (Research Institutes, etc.)
  • 13.7. Market Value Forecast By Country/Sub-region ,2020 to 2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Test Type
    • 13.8.2. By Product
    • 13.8.3. By Technology
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Non-invasive Prenatal Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Test Type, 2020 to 2035
    • 14.2.1. Cell-Free DNA Screening Test
    • 14.2.2. Serum Marker Screening Test
    • 14.2.3. Neural Tube Defects Test
    • 14.2.4. Ultrasonography
  • 14.3. Market Value Forecast By Product, 2020 to 2035
    • 14.3.1. Instruments
    • 14.3.2. Kits & Reagents
  • 14.4. Market Value Forecast By Technology, 2020 to 2035
    • 14.4.1. Whole-Genome Sequencing
    • 14.4.2. SNP Analysis
    • 14.4.3. Microarray Analysis
    • 14.4.4. Rolling Circle Amplification
  • 14.5. Market Value Forecast By Indication, 2020 to 2035
    • 14.5.1. Down Syndrome (trisomy 21)
    • 14.5.2. Edwards syndrome (trisomy 18)
    • 14.5.3. Patau syndrome (trisomy 13)
    • 14.5.4. Turner Syndrom (Monosomy X/XO)
    • 14.5.5. Klinefelter Syndrome (XXY)
    • 14.5.6. Jacob's Syndrome (XYY)
    • 14.5.7. Gender Identification
    • 14.5.8. Others (Triple X, etc.)
  • 14.6. Market Value Forecast By End-user, 2020 to 2035
    • 14.6.1. Hospitals
    • 14.6.2. Specialty Clinics
    • 14.6.3. Diagnostics Laboratories
    • 14.6.4. Others (Research Institutes, etc.)
  • 14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.7.1. China
    • 14.7.2. India
    • 14.7.3. Japan
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Test Type
    • 14.8.2. By Product
    • 14.8.3. By Technology
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Test Type, 2020 to 2035
    • 15.2.1. Cell-Free DNA Screening Test
    • 15.2.2. Serum Marker Screening Test
    • 15.2.3. Neural Tube Defects Test
    • 15.2.4. Ultrasonography
  • 15.3. Market Value Forecast By Product, 2020 to 2035
    • 15.3.1. Instruments
    • 15.3.2. Kits & Reagents
  • 15.4. Market Value Forecast By Technology ,2020 to 2035
    • 15.4.1. Whole-Genome Sequencing
    • 15.4.2. SNP Analysis
    • 15.4.3. Microarray Analysis
    • 15.4.4. Rolling Circle Amplification
  • 15.5. Market Value Forecast By Indication, 2020 to 2035
    • 15.5.1. Down Syndrome (trisomy 21)
    • 15.5.2. Edwards syndrome (trisomy 18)
    • 15.5.3. Patau syndrome (trisomy 13)
    • 15.5.4. Turner Syndrom (Monosomy X/XO)
    • 15.5.5. Klinefelter Syndrome (XXY)
    • 15.5.6. Jacob's Syndrome (XYY)
    • 15.5.7. Gender Identification
    • 15.5.8. Others (Triple X, etc.)
  • 15.6. Market Value Forecast By End-user, 2020 to 2035
    • 15.6.1. Hospitals
    • 15.6.2. Specialty Clinics
    • 15.6.3. Diagnostics Laboratories
    • 15.6.4. Others (Research Institutes, etc.)
  • 15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Test Type
    • 15.8.2. By Product
    • 15.8.3. By Technology
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Non-invasive Prenatal Testing Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Test Type, 2020 to 2035
    • 16.2.1. Cell-Free DNA Screening Test
    • 16.2.2. Serum Marker Screening Test
    • 16.2.3. Neural Tube Defects Test
    • 16.2.4. Ultrasonography
  • 16.3. Market Value Forecast By Product, 2020 to 2035
    • 16.3.1. Instruments
    • 16.3.2. Kits & Reagents
  • 16.4. Market Value Forecast By Technology, 2020 to 2035
    • 16.4.1. Whole-Genome Sequencing
    • 16.4.2. SNP Analysis
    • 16.4.3. Microarray Analysis
    • 16.4.4. Rolling Circle Amplification
  • 16.5. Market Value Forecast By Indication, 2020 to 2035
    • 16.5.1. Down Syndrome (trisomy 21)
    • 16.5.2. Edwards syndrome (trisomy 18)
    • 16.5.3. Patau syndrome (trisomy 13)
    • 16.5.4. Turner Syndrom (Monosomy X/XO)
    • 16.5.5. Klinefelter Syndrome (XXY)
    • 16.5.6. Jacob's Syndrome (XYY)
    • 16.5.7. Gender Identification
    • 16.5.8. Others (Triple X, etc.)
  • 16.6. Market Value Forecast By End-user, 2020 to 2035
    • 16.6.1. Hospitals
    • 16.6.2. Specialty Clinics
    • 16.6.3. Diagnostics Laboratories
    • 16.6.4. Others (Research Institutes, etc.)
  • 16.7. Market Value Forecast By Country/Sub-region ,2020 to 2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Test Type
    • 16.8.2. By Product
    • 16.8.3. By Technology
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. F. Hoffmann-La Roche Ltd
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Natera, Inc.
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Illumina, Inc
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. PerkinElmer Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eurofins LifeCodexx AG
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. IGENOMIX
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Pacific Biosciences
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. BGI
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Laboratory Corporation of America Holdings
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Agilent Technologies, Inc.
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Berry Genetics Inc.
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments